Skip to content

Allphase Pharma Consulting, LLC

A Professional Service Provider for the Pharma Industry

Allphase Pharma Consulting, LLC
Menu

Primary menu

  • CONTACT
  • BLOGS
    • The Viewpoint
    • The News
    • Recent Literature
    • Did you know…?
    • QIDP Antibiotics
  • LEGAL
  • WELCOME

Secondary menu

  • The News
  • The Viewpoint
  • Did you know…?
  • Recent Literature
  • QIDP Antibiotics

Tag Archives: bacterial dialysis

Two New Approaches For Dealing with Sepsis / Toxemia

Posted on November 17, 2014 by Harald — No Comments ↓

There is hardly an indication which has accumulated more failed clinical trials than the sepsis area.  Called first bacteremia, later sepsis, sepsis syndrome or septic shock, there have been numerous attempts to influence the cascade of events that eventually lead to MSOF and death.  While it is convenient to think Continue reading Two New Approaches For Dealing with Sepsis / Toxemia→

Share this:

  • Click to share on LinkedIn (Opens in new window) LinkedIn
  • Click to share on Facebook (Opens in new window) Facebook
  • Click to share on X (Opens in new window) X
  • Click to print (Opens in new window) Print
  • Click to email a link to a friend (Opens in new window) Email
  • Click to share on WhatsApp (Opens in new window) WhatsApp

Like this:

Like Loading...
Posted in Recent Literature, The Viewpoint | Tagged antibiotic blog, bacteremia, bacterial dialysis, bacterial trapping, Bayer, dialysis, drotrecogin, E5 mAb, Eisai, endotoxin, Eritoran, HA1A, Lilly, liposomes, LPS, mannose-binding protein, MBP, MSOF, multi-system organ failure, nanoparticles, Roger Bone, sepsis, sepsis syndrome, septic shock, steroids, TFPI, Tifacogin, TNF-alpha inhibitor, toxemia, toxin binding, Xigris | Leave a reply

Go back

Your message has been sent

Rating(required)
Warning

Footer Menu

Footer menu

  • CONTACT
  • BLOGS
  • LEGAL
  • WELCOME
  • Email
Copyright © 2026 Allphase Pharma Consulting, LLC. All Rights Reserved.
Theme: Catch Box by Catch Themes
Scroll Up
%d